New patent expiration for Merck Sharp drug DUTREBIS

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for DUTREBIS
Annual Drug Patent Expirations for DUTREBIS

Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are five patents protecting this drug.

This drug has forty-six patent family members in thirty-four countries.

The generic ingredient in DUTREBIS is lamivudine; raltegravir potassium. Additional details are available on the lamivudine; raltegravir potassium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top